Lotuseye
Live Price
Recent news and updates for LOTUSEYE will appear here soon.
"Caution advised for LOTUSEYE investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
As of the latest market session, Lotuseye (LOTUSEYE) is trading at ₹110.59, representing a move of -2.91% from the previous close.
Lotuseye is listed and traded under the ticker symbol LOTUSEYE on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Lotuseye's stock price moved by -2.91%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 35% bullish probability for LOTUSEYE stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Lotuseye shares reached a high of ₹147 and hit a low of ₹97.59.
LOTUSEYE exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 16,668 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Lotuseye has a market capitalization of ₹229.99 Cr, designating its size class inside the Healthcare sector.
Lotuseye has a current dividend yield of N/A. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Lotuseye's trailing Price-to-Earnings (P/E) ratio is 1382.38. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Lotuseye (LOTUSEYE) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Lotuseye's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore LOTUSEYE's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for LOTUSEYE are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Lotuseye operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.